July 13, 2021 -- Abcam has opened a new 100,000-sq-ft facility in Waltham, MA, to serve as a hub for its research and development (R&D) and commercial activities in the region.
The facility will more than double Abcam's capacity at its previous site in Cambridge, MA, and will eventually house about 300 employees, according to the company. The new site will increase the company's flexibility, scale, and capacity in R&D, production, distribution, and customer service for biopharma partners and life science researchers.
Abcam provides reagents to support development of diagnostics, vaccines, and potential therapeutics.